Results 81 to 90 of about 2,726 (200)

Intravenous ferric carboxymaltose is associated with lowering of plasma phosphate levels in patients with gastric bypass surgery: a retrospective case series

open access: yesSwiss Medical Weekly
AIMS: Bariatric surgery induces several micronutrient deficiencies that require supplementation. For iron, parenteral infusions are usually preferred over oral supplementation.
Cindy Pereira Portela   +3 more
doaj   +1 more source

Transient imaging changes accompany ‘spinal ICANS’ following CAR T‐cell therapy for large B‐cell lymphoma in adults

open access: yes
British Journal of Haematology, Volume 207, Issue 6, Page 2632-2637, December 2025.
Frederick W. Vonberg   +14 more
wiley   +1 more source

Transient hypophosphataemia associated with acute infectious disease in paediatric patients

open access: yes, 2002
The aim of this study was to investigate the prevalence of hypophosphataemia in children with acute infection and the relationship between serum phosphate and C-reactive protein (CRP) concentration.
Bakoula, C.   +5 more
core  

Refeeding Hypophosphatemia in Adolescents With Anorexia Nervosa: A Systematic Review [PDF]

open access: yes, 2013
The rate of adolescents presenting with anorexia nervosa (AN) is increasing. Medically unstable adolescents are admitted to the hospital for nutrition restoration. A lack of global consensus on appropriate refeeding practices of malnourished patients has
Nicholls, D   +3 more
core   +1 more source

Differences in adverse events between manuscript and drug labels for myeloma T‐cell‐redirecting therapies

open access: yes
British Journal of Haematology, Volume 207, Issue 4, Page 1659-1663, October 2025.
Bita Bashy   +5 more
wiley   +1 more source

Incidence of hypophosphataemia in patients on parenteral nutrition

open access: yes, 2020
OBJECTIVE - To determine the effect of parenteral nutrition on plasma phosphate levels and to evaluate the incidence of refeeding hypophosphataemia.
Marvin, V   +3 more
core  

Hypophosphataemia at a large academic hospital in South Africa

open access: yes, 2008
Aim: The aim of this study was to determine the most common causes of hypophosphataemia (≤ 0.5 mmol/l) in a hospital population in order to identify patient groups at risk of developing the condition.
Zemlin A.E.   +3 more
core   +1 more source

Improvements with burosumab treatment in an early access programme for adults with X-linked hypophosphataemia: A case series of three patients

open access: yesBone Reports
X-linked hypophosphataemia (XLH) is a life-long phosphate-wasting disorder that causes skeletal deformities, pain, stiffness, and fatigue and impairs quality of life. Burosumab was approved for use in adults in 2020.
Julia Day   +2 more
doaj   +1 more source

Incidence of hypophosphataemia in patients on parenteral nutrition

open access: yes, 2007
OBJECTIVE - To determine the effect of parenteral nutrition on plasma phosphate levels and to evaluate the incidence of refeeding hypophosphataemia.
Marvin, V   +3 more
core  

Pediatric Drugs / New developments in the treatment of X-linked hypophosphataemia : implications for clinical management

open access: yes, 2020
X-linked hypophosphataemia (XLH) is due to mutations in phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) and represents the most common heritable form of rickets.
Saraff, Vrinda   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy